Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Supplement Industry Has Weapons Available To Fight Consumer Distrust

This article was originally published in The Tan Sheet

Executive Summary

More than half of U.S. consumers distrust claims made by supplement and nutritional manufacturers, according to a recent survey, but trade groups say firms can overcome consumer suspicions by self-regulating and grounding claims in science

You may also be interested in...



CRN extends NAD grant for ad review

The Council for Responsible Nutrition and the National Advertising Review Council extend through October 2014 their supplement advertising review program established in 2006, according to a Nov. 9 release (1"The Tan Sheet" Sept. 25, 2006). Under the extension, the recently established CRN Foundation incrementally will grant $959,000 to NARC's National Advertising Division beginning Nov. 1. "This initiative reflects one of the CRN Foundation's objectives - 'to promote truthful and non-misleading advertising of dietary supplements to consumers through programs that encourage self-regulation of advertising by industry members,'" said CRNF Executive Director Steve Mister, also the trade group's president and CEO. Mister called on dietary supplement firms to "file competitive challenges with NAD when they see dietary supplement advertisements that" disserve the industry. NAD Director Andrea Levine said, "With CRN's support, we have demonstrated that self-regulation can play an active and visible role in combating misleading and unsubstantiated dietary supplement claims, but there is still significant work left to be done.

People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands

Topics

UsernamePublicRestriction

Register

PS104301

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel